A new blood can spot ‘hidden’ aggressive prostate cancer tumours by analysing proteins and genes, new research has found. The STHLM3 test was trialled in a large group of 58,818 men to see what difference it made to diagnosing dangerous cancers earlier. Not only was it far more reliable than the standard PSA blood test, but it also revealed the presence of potentially lethal cancers that could easily be missed. Read more